The present invention relates to sublingual films of Salbutamol comprising Salbutamol or pharmaceutically acceptable salts thereof and pharmaceutically acceptable excipients with a diffusion flux of 3-80µg/cm2/min through biological mucosal membranes equivalent to human oral mucosa.

A taste masked orally dissolving strip formulation of amlodipine or pharmaceutically acceptable salts thereof comprising amlodipine or pharmaceutically acceptable salts thereof, surfactant, taste masking agent, flavoring agent, water soluble polymeric component and at least one pharmaceutically acceptable excipient....

An orally dissolving strip formulation of montelukast or pharmaceutical^ acceptable salts thereof comprising montelukast or pharmaceutically acceptable salts, water soluble polymeric component and at least one pharmaceutically acceptable excipient

SUBLINGUAL FILM OF KETOROLAC Abstract The present invention relates to sublingual films of Ketorolac comprising Ketorolac or pharmaceutically acceptable salts thereof and pharmaceutically acceptable excipients with a diffusion flux of 10-110µg/cm2/min through biological mucosal membranes equivalent to human or...

The present invention relates to sublingual films of Terbutaline comprising Terbutaline or pharmaceutically acceptable salts thereof and pharmaceutically acceptable excipients with a diffusion flux of 9-105µg/cm2/min through biological mucosal membranes equivalent to human oral mucosa.